Visiopharm Corporation

Visiopharm Corporation (doing business as Visiopharm Corp), a foreign-owned for-profit organization headquartered in Broomfield, Colorado and a wholly-owned subsidiary of Denmark-based Visiopharm A/S, provides precision pathology software, digital microscopy solutions, and AI-driven biomarker analysis systems to federal research and health agencies as a prime contractor across all recent awards. The vendor competes under full-and-open procurement without set-aside designations, with one exception: a $82,190 Defense Health Agency purchase order for OCUS40 digital microscopes that utilized Total Small Business set-aside.

Visiopharm's capability footprint centers on digital pathology software platforms, tissue and cell imaging analysis tools, and multiplexed biomarker phenotyping systems designed for research diagnostics and precision medicine. Representative work includes a $30,000 one-year service maintenance contract with Veterans Integrated Service Network 20 (awarded July 2026) covering a Perpetual Service Level Plan supporting up to three users, unlimited remote technical support, and eight annual training sessions for imaging analysis supporting posttraumatic stress disorder and traumatic brain injury research at the Puget Sound VA Health Care System; a $68,800 digital pathology subscription with the National Institute of Environmental Health Sciences (August 2024); and a $168,584.91 purchase order from Veterans Integrated Service Network 8 (May 2022) for three biomarker analysis systems with PD-L1 cancer detection algorithms. The vendor also supplies software upgrades, such as a $46,007.55 PHENOPLEX software upgrade (NIEHS, August 2024), and specialized diagnostic instruments like digital microscopes.

Customer concentration is weighted toward Veterans Health Administration and the National Institutes of Health. Veterans Integrated Service Network 20 leads on both award count and dollars (5 awards, $279 thousand combined potential value), while NIEHS is the second-largest customer (4 awards, $262 thousand combined potential value). The top five funding agencies account for 76% of recent awards by count and 83% by combined potential value, with the National Cancer Institute, Veterans Integrated Service Network 8, the Food and Drug Administration, and the National Heart Lung and Blood Institute rounding out the active set. The vendor has worked with nine distinct federal agencies over the past five years.

Total federal award volume is $1.1 million across 17 prime contracts, with 98% obligated. Activity has been sporadic — two awards in 2021, three in 2022, two in 2023, three in 2024, and one in the first half of 2026 — rather than showing consistent growth trajectory. Visiopharm operates exclusively as a prime contractor with no subcontract footprint in the source data. The vendor's awards are categorized primarily under Software Publishers (4 awards) and Analytical Laboratory Instrument Manufacturing (3 awards) NAICS codes, with procurement service categories split between IT and Telecom Business Application Software (5 awards) and Laboratory Equipment and Supplies (4 awards).